MARKET

INVA

INVA

Innoviva
NASDAQ
17.57
+0.38
+2.21%
Opening 13:49 07/22 EDT
OPEN
17.29
PREV CLOSE
17.19
HIGH
17.62
LOW
17.22
VOLUME
111.76K
TURNOVER
0
52 WEEK HIGH
17.62
52 WEEK LOW
12.22
MARKET CAP
1.10B
P/E (TTM)
7.89
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at INVA last week (0715-0719)?
Weekly Report · 8h ago
FHLC: Healthcare Dashboard For July
Seeking Alpha · 5d ago
Weekly Report: what happened at INVA last week (0708-0712)?
Weekly Report · 07/15 09:11
15 Healthcare Stocks Hit New Highs: Did You Spot These Winners?
NASDAQ · 07/14 05:59
Weekly Report: what happened at INVA last week (0701-0705)?
Weekly Report · 07/08 09:11
Weekly Report: what happened at INVA last week (0624-0628)?
Weekly Report · 07/01 09:12
Weekly Report: what happened at INVA last week (0617-0621)?
Weekly Report · 06/24 09:12
Innoviva: Potentially Overvalued
Seeking Alpha · 06/21 12:30
More
About INVA
Innoviva, Inc. is a diversified holding company with a portfolio of royalties and other healthcare assets. The Company's royalty portfolio consists of respiratory assets partnered with Glaxo Group Limited (GSK), including RELVAR/BREO ELLIPTA (fluticasone furoate/vilanterol, FF/VI) and ANORO ELLIPTA (umeclidinium bromide/vilanterol, UMEC/VI). Under the Long-Acting Beta2 Agonist (LABA) Collaboration Agreement, the Company is entitled to receive royalties from GSK on sales of RELVAR/BREO ELLIPTA. The Company's products include GIAPREZA and XERAVA. GIAPREZA (angiotensin II) injection is approved by the United States Food and Drug Administration (FDA) as a vasoconstrictor indicated to increase blood pressure in adults with septic or other distributive shock. XERAV (eravacycline) for injection is approved by the United States FDA and Singapore Health Sciences Authority (HSA) as a tetracycline class antibacterial indicated for the treatment of complicated intra-abdominal infections (cIAI).

Webull offers Innoviva Inc stock information, including NASDAQ: INVA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, INVA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading INVA stock methods without spending real money on the virtual paper trading platform.